systematic_review
2007
Safety considerations with omega-3 fatty acid therapy
Bays HE
Published in American Journal of Cardiology
Methodology
Review of safety data from omega-3 trials including bleeding-related adverse events.
Key Findings
Omega-3 prolongs bleeding time modestly but clinically significant bleeding was not increased, including with antiplatelet or anticoagulant co-therapy.
Conclusions
Fish oil rarely causes clinically important bruising or bleeding at usual doses.
Limitations
Author industry ties; narrative safety synthesis.
Supplements Studied
Omega-3 Fatty Acids
Fatty Acid
Omega-3 prolongs bleeding time modestly but clinically significant bleeding was not increased.
Related Health Concerns
Study Details
Year:2007
Sample Size:5,000
Quality Score:6/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.